DNMT3A and pulmonary arterial hypertension: This review was inspired by published research in our laboratory that identified somatic and germline mutations of TET2 as predisposing to inflammation [19] and PAH [20] and emerging research, suggesting that somatic mutations in DNMT3A may also promote inflammation and PAH.